EPILACTOSE
|
- $65 - $2194.5
- Product name: EPILACTOSE
- CAS: 20869-27-6
- MF: C12H22O11
- MW: 342.3
- EINECS:
- MDL Number:MFCD00070338
- Synonyms:4-O-BETA-GALACTOPYRANOSYL-D-MANNOPYRANOSIDE;EPILACTOSE;4-O-B-galactopyranosyl-D-mannopyranose;2-epi-Lactose;4-O-b-Galactopyranosyl-D-mannopyranoside;4-o-β-galactopyranosyl-d-mannopyranose;4-O-SS-GALACTOPYRANOSYL-D-MANNOPYRANOSIDE;4-O-beta-D-Galactopyranosyl-D-mannopyranose
7 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
- TRC
- Usbiological
Package
- 2.5mg
- 10MG
- 25mg
- 100MG
- 250mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCRB0000293
- Product description4-O-BETA-GALACTOPYRANOSYL-D-MANNOPYRANOSIDE 95.00%
- Packaging10MG
- Price$779.63
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCRB0000293
- Product description4-O-BETA-GALACTOPYRANOSYL-D-MANNOPYRANOSIDE 95.00%
- Packaging100MG
- Price$2194.5
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberG0886
- Product description4-O-β-Galactopyranosyl-D-mannopyranose ≥98% (GC)
- Packaging25mg
- Price$203
- Updated2025-07-31
- Buy
- ManufacturerSigma-Aldrich
- Product numberG0886
- Product description4-O-β-Galactopyranosyl-D-mannopyranose ≥98% (GC)
- Packaging100mg
- Price$434
- Updated2025-07-31
- Buy
- ManufacturerTRC
- Product numberG154850
- Product description4-O-β-Galactopyranosyl-D-mannopyranoside
- Packaging10mg
- Price$65
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberG154850
- Product description4-O-β-Galactopyranosyl-D-mannopyranoside
- Packaging250mg
- Price$430
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number448299
- Product descriptionepi-Lactose
- Packaging2.5mg
- Price$425
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CRB0000293 | 4-O-BETA-GALACTOPYRANOSYL-D-MANNOPYRANOSIDE 95.00% | 10MG | $779.63 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CRB0000293 | 4-O-BETA-GALACTOPYRANOSYL-D-MANNOPYRANOSIDE 95.00% | 100MG | $2194.5 | 2021-12-16 | Buy |
| Sigma-Aldrich | G0886 | 4-O-β-Galactopyranosyl-D-mannopyranose ≥98% (GC) | 25mg | $203 | 2025-07-31 | Buy |
| Sigma-Aldrich | G0886 | 4-O-β-Galactopyranosyl-D-mannopyranose ≥98% (GC) | 100mg | $434 | 2025-07-31 | Buy |
| TRC | G154850 | 4-O-β-Galactopyranosyl-D-mannopyranoside | 10mg | $65 | 2021-12-16 | Buy |
| TRC | G154850 | 4-O-β-Galactopyranosyl-D-mannopyranoside | 250mg | $430 | 2021-12-16 | Buy |
| Usbiological | 448299 | epi-Lactose | 2.5mg | $425 | 2021-12-16 | Buy |
Properties
Melting point :208-210°C
Boiling point :667.9±55.0 °C(Predicted)
Density :1.76±0.1 g/cm3(Predicted)
storage temp. :-20°C Freezer, Under Inert Atmosphere
solubility :H2O: soluble49.00 - 51.00 mg/mL, clear to very slightly hazy, colorless
form :Solid
pka :12.02±0.70(Predicted)
color :White to Pale Yellow
Stability :Hygroscopic
InChI :InChI=1/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8+,9-,10-,11+,12+/s3
InChIKey :GUBGYTABKSRVRQ-YBDWKALUNA-N
SMILES :[C@@H]1([C@H](O)[C@@H]([C@@H](O)O[C@@H]1CO)O)O[C@H]1[C@H](O)[C@H]([C@@H](O)[C@@H](CO)O1)O |&1:0,1,3,4,7,12,13,15,16,18,r|
Boiling point :667.9±55.0 °C(Predicted)
Density :1.76±0.1 g/cm3(Predicted)
storage temp. :-20°C Freezer, Under Inert Atmosphere
solubility :H2O: soluble49.00 - 51.00 mg/mL, clear to very slightly hazy, colorless
form :Solid
pka :12.02±0.70(Predicted)
color :White to Pale Yellow
Stability :Hygroscopic
InChI :InChI=1/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8+,9-,10-,11+,12+/s3
InChIKey :GUBGYTABKSRVRQ-YBDWKALUNA-N
SMILES :[C@@H]1([C@H](O)[C@@H]([C@@H](O)O[C@@H]1CO)O)O[C@H]1[C@H](O)[C@H]([C@@H](O)[C@@H](CO)O1)O |&1:0,1,3,4,7,12,13,15,16,18,r|
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
